Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: Clinical features and molecular pathogenesis

Blood

Volumn 87, Issue 4, 1996, Pages 1211-1224

  Hunger, Stephen P ^a,b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYBRID PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; CHROMOSOME PAINTING; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOPHENOTYPING; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0030056354     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1211.bloodjournal8741211     Document Type: Review

References (141)

1. Kadesch T: Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today 13:31, 1992
2. Schlissel M, Voronova A, Baltimore D: Helix-loop-helix transcription factor E47 activates germ line immunoglobulin heavy-chain transcription and rearrangement in a pre-T-cell line. Genes Dev 5:1367, 1991
3. Church GM, Ephrussi A, Gilbert W, Tonegawa S: Cell type specific contacts to immunoglobulin enhancers in nuclei. Nature 313:798, 1985
4. Ephrussi A, Church GM, Tonegawa S, Gilbert W: B-lineage specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134, 1985
5. Sen R, Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705, 1986
6. Murre C, McCaw PS, Baltimore D: A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777, 1989
7. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB, Weintraub H, Baltimore D: Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537, 1989
8. Sun X-H, Baltimore D: An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64:459, 1991
9. Henthorn P, Kuedjian M, Kadesch T: Two distinct transcription factors that bind the immunoglobulin enhancer μE5/κE2 motif. Science 247:467, 1990
10. Henthorn P, McCarrick-Walmsley R, Kadesch T: Sequence of the cDNA encoding ITF-1, a positive-acting transcription factor. Nucleic Acids Res 18:677, 1990
11. Cronmiller C, Schedl P, Cline TY: Molecular characterization of daughterless, a Drosophila sex determination gene with multiple roles in development. Genes Dev 2:1666, 1988
12. Caudy M, Vässin H, Brand M, Tuma R, Jan LY, Jan YN: daughterless, a Drosophila gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaetescute complex. Cell 55:1061, 1988
13. Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987, 1987
14. Blackwell TK, Weintraub H: Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104, 1990
15. Ellenberger T, Fass D, Arnaud M, Hamson SC: Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes Dev 8:970, 1994
16. Aronheim A, Shiran R, Rosen A, Walker MD: The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc Natl Acad Sci USA 90:8063, 1993
17. Quong MW, Massari ME, Zwant R, Murre C: A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol Cell Biol 13:792, 1993
18. Nelson C, Shen LP, Meister A, Fodor E, Rutter WJ: Pan: A transcriptional regulator that binds chymotrypsin, insulin and AP-4 enhancer motifs. Genes Dev 4:1035, 1990
19. Cordle SR, Henderson E, Masuoka H, Weil PA, Stein R: Pancreatic beta-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA binding proteins. Mol Cell Biol 11:1734, 1991
20. Lassar AB, Murre C, Davis RL, Voronova A, Wright WE, Baltimore D, Kadesch T, Weintraub H: Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305, 1991
21. Murre C, Voronova A, Baltimore D: B-cell- and monocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol Cell Biol 11:1156, 1991
22. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H: The protein Id: A negative regulator of helix-loop-helix DNA-binding proteins. Cell 61:49, 1990
23. Christy BA, Sanders LK, Lau LF, Copeland NG, Jenkins NA, Nathans D: An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc Natl Acad Sci USA 88:1815, 1991
24. Sun X-H, Copeland NG. Jenkins NA, Baltimore D: Id proteins. Id1 and Id2, selectively inhibit DNA binding by one class of helix-loop helix proteins. Mol Cell Biol 11:5603, 1991
25. Riechmann V, van Cruchten I, Sablilzky F: The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res 22:749, 1994
26. Bain G, Gruenwald S, Murre C: E2A and E2-2 are subunits of B-cell specific E2-box DNA-binding proteins. Mol Cell Biol 13:3522, 1993
27. Benezra R: An intermolecular disulfide bond stabilizes E2A homodimers and is required for DNA binding at physiological temperatures. Cell 79:1057, 1994
28. Bain G, Robanus Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, van der Valk M, te Riele HPJ, Berns A, Murre C: E2A proteins are required for proper B-cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885, 1994
29. Zhuang Y, Soriano P, Weintraub H: The helix-loop-helix gene E2A is required for B-cell formation. Cell 79:875, 1994
30. Sun X-H: Constitutive expression of the Id1 gene impairs mouse B-cell development Cell 79:893, 1994
31. 1 progression by E2A and Id helix-loop-helix proteins. EMBO J 13:4291, 1994
32. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143, 1994
33. Mellentin JD, Murre CM, Donlon TA, McCaw PS, Smith SD, Carroll AJ, McDonald ME, Baltimore D, Cleary ML: The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 246:379, 1989
34. Kamps MP, Murre CM, Sun X-H, Baltimore D: A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60:547, 1990
35. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML: Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535, 1990
36. Hunger SP, Galili N, Carroll AJ, Crist WM, Link M, Cleary ML: The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 77:687, 1991
37. Hunger SP, Ohyashiki K, Toyama K, Cleary ML: HLF, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 6:1608, 1992
38. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT: Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257:531, 1992
39. Carroll AJ, Crist WM, Parmley RT, Roper M, Cooper MD, Finley WH: Pre-B-cell leukemia associated with chromosome translocation 1;19. Blood 63:721, 1984
40. Garry MB, Grindley RM: Translocation between chromosomes 1 and 19 in acute lymphoblastic leukemia. Cancer Genet Cytogenet 13:343, 1984
41. Michael PM, Levin MD, Garson OM: Translocation 1;19-A new cytogenetic abnormality in acute lymphoblastic leukemia. Cancer Genet Cytogenet 12:333, 1984
42. Williams DL, Look AT, Melvin SL, Robertson PK, Dahl G, Flake T, Stass S: New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 36:101, 1984
43. Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vieti TJ, Look AT, Mahoney D, Ragab A, Pullen DJ, Land VJ: Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23:p13). A Pediatric Oncology Group Study. Blood 76:117, 1990
44. Raimondi SC, Behm FG, Roberson PK, Williams DL Pui C-H, Crist WM, Look AT, Rivera GK: Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 8:1380, 1990
45. Pui C-H: Childhood leukemias. N Engl J Med 332:1618, 1995
46. Miyamoto K, Tomita N, Ishii A, Nonaka H, Kondo T, Tanaka T, Kitajima K: Chromosome abnormalities of leukemia cells in adult patients with T-cell leukemia. J Natl Cancer Inst 73:353, 1984
47. Yamada T, Craig JM, Hawkins JM, Janossy G, Seeker-Walker LM: Molecular investigation of 19p13 in standard and variant translocations: The E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotype. Leukemia 5:36, 1991
48. Seeker-Walker LM, Berger R, Fenaux P, Lai JL, Nelken B, Garson M, Michael PM, Hagemeijer A, Harrison CJ, Kaneko Y, Rubin CM: Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 6:363, 1992
49. Ohno H, Inoue T, Akasaka T, Okumura A, Miyanishi S, Ohashi I, Kikuchi M, Masuya M, Amano H, Imanaka T, Ohno Y-i: Acute lymphoblastic leukemia associated with a t(1;19) (q23;p13) in an adult. Intern Med 32:584, 1993
50. Vagner-Capodano A-M, Mozziconacci MJ, Zattara-Cannoni H, Guitard AM, Thuret I, Michel G: t(1;19) in a M4-ANLL. Cancer Genet Cytogenet 73:86, 1994
51. Wlodarska I, Stul M, DeWolf-Peeters C, Verhoef G, Mecucci C, Cassiman JJ, Van den Berghe H: t(1;19) without detectable E2A rearrangements in two t(14;18)-positive lymphoma/leukemia cases. Genes Chromosom Cancer 10:171, 1994
52. Shikano T, Kaneko Y, Takazawa M, Ueno N, Ohkawa M, Fujimoto T: Balanced and unbalanced 1;19 translocation-associated acute lymphoblastic leukemias. Cancer 58:2239, 1986
53. Pui C-H, Raimondi SC, Hancock ML, Rivera GK, Ribeiro RC, Mahmoud HH, Sandlund JT, Crist WM, Behm FG: Immunologie, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 12:2601, 1994
54. Vagner-Capodano A-M, Michel G, Maraninchi D, Tubiana N, Gouzien M, Perrimond H, Carcassonne Y: Poor prognosis of acute lymphoblastic leukemia with translocation (1,19) in childhood: Potential interest of allogeneic bone marrow transplantation. Ann Genet 31:53, 1988
55. Crist W, Boyett J, Roper M, Pullen J, Metzgar R, van Eys J, Ragab A, Starling K, Vietti T, Cooper M: Pre-B-cell leukemia responds poorly to treatment: A Pediatric Oncology Group study. Blood 63-407, 1984
56. Pui C-H, Williams DL, Kalwinsky DK, Look AT, Melvin SL, Dodge RK, Rivera G, Murphy SB, Dabi GV: Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia. Blood 67:1688, 1986
57. Crist W, Boyett J, Jackson J, Vietti T, Borowitz M, Chauvenet A, Winick N, Ragab A, Mahoney D, Head D, Iyer R, Wagner H, Pullen J: Prognostic importance of the pre-B immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study Blood 74:1252, 1989
58. Look AT, Roberson PK, Williams DL, Rivera G, Bowman WP, Pui C-H, Ochs J, Abromowitch M, Kalwinsky D, Dahl GV, George S, Murphy SB: Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 65:1079, 1985
59. Jackson JF, Boyett J, Pullen J, Brock B, Patterson R, Land V, Borowitz M, Head D, Crist W: Favorable prognosis associated with hyperdiploidy in children with acute lymphoblastic leukemia correlates with extra chromosome 6. A pediatric oncology group study. Cancer 66:1183, 1990
60. Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A, Frankel L, Harris M, Wagner H, Haggard M, Mosijczuk A, Steuber P, Land V: Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 10:606, 1992
61. Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carroll AJ, Baltimore D, Look AT: Different molecular consequences of the 1:19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood 79:1781, 1992
62. Izraeli S, Henn T, Strobl H, Ludwig WD, Kovar H, Haas OD, Harbott J, Bartram CR, Gardner H, Lion T: Expression of identical E2A-PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia. Leukemia 7:2054, 1993
63. Devaraj PE, Foroni L, Janossy G, Hoffbrand AV, Seeker-Walker LM: Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Leukemia 9:821, 1995
64. Troussard X, Rimokh R, Valensi F, Leboeuf D, Fenneteau O, Guitard A-M, Manel A-M, Schillenger F, Leglise C, Brizard A, Gardais J, Lessard M, Flandrin G, MacIntyre E: Heterogeneity of t(1;19)(q23;p13) acute leukemias. Br J Haematol 89:516, 1995
65. Troussard X, Valensi F, Salamon-Nguyen F, Debert C, Flandrin G, MacIntyre E: Correlation of cytoplasmic Ig μ (Cμ) and E2A-PBX1 fusion transcripts in t(1;19) B lineage ALL: Discrepancy in Cμ detection by slide immunofluorescence and flow cytometry. Leukemia 9:518, 1995 (letter)
66. Rieder H, Kolbus U, Koop U, Ludwig WD, Stollmann-Gibbels B, Fonatsch C: Translocation t(1;22) mimicking t(1;19) in a child with acute lymphoblastic leukemia as revealed by chromosome painting. Leukemia 7:1663, 1993
67. Borowitz MJ, Hunger SP, Carroll AJ, Shuster JJ, Pullen DJ, Steuber PJ, Cleary ML: Predictability of the t(1;19)(q23;p13) from surface antigen phenotype. Implications for screening cases of childhood ALL for molecular analysis. A Pediatric Oncology Group study. Blood 82:1086, 1993
68. Mellentin JD, Nourse J, Hunger SP, Smith SD, Cleary ML: Molecular analysis of the t(1;19) breakpoint cluster region in pre-B-cell ALL. Genes Chromosom Cancer 2:239, 1990
69. Numata S, Kato K, Horibe K: New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia Leukemia 7:1441, 1993
70. Izraeli S, Kovar H, Gadner H, Lion T: Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. Blood 80:1413, 1992
71. Privitera E, Luciano A, Ronchetti D, Arico M, Santostasi T, Basso G, Biondi A: Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 8:554, 1994
72. Izraeli S, Janssen WSG, Haas OA, Harbott J, Brok-Simoni F, Walher JU, Kovar H, Henn T, Ludwig W-D, Reiter A, Rechavi G, Bartram CR, Gadner H, Lion T: Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: A comparison between cytogenetic and polymerase chain reaction analyses. Leukemia 7:671, 1993
73. McGinnis W, Levine M, Hafen E, Kuroiwa A, Gehring WJ: A conserved DNA sequence found in homeotic genes of the Drosophila Antennapedia and bithorax complexes. Nature 308:428, 1984
74. Scott MP, Weiner A: Structural relationship among genes that control development: Sequence homology between the Antennapedia, Ultrabithorax, and fushi tarazu loci of Drosophila. Proc Natl Acad Sci USA 81:4115, 1984
75. Monica K, Galili N, Nourse J, Saltman D, Cleary ML: PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol Cell Biol 11:6149, 1991
76. Van Dijk MA, Voorhoeve M, Murre C: Pbx1 is converted into a transcriptional activator upon acquiring the N-terrninal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 90:6061, 1993
77. LeBrun DP, Cleary ML: Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias. Oncogene 9:1641, 1994
78. Lu Q, Wright DD, Kamps MP: Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1:19). Mol Cell Biol 14:3938, 1994
79. Duboule D, Dolle P: The structural and functional organization of the murine HOX gene family resembles that of Drosophila. EMBO J 8:1497, 1989
80. Graham A, Papalopulu N, Krumlauf R: The murine and Drosophila homeobox gene complexes have common features of organization and expression. Cell 57:367, 1989
81. Scott MP, Tamkan JW, Hartzell GW III: The structure and function of the homeodomain. Biochim Biophys Acta 989:25, 1989
82. Chisaka O, Capecchi MR: Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene Hox-1 5. Nature 350:473, 1991
83. Lufkin T, Dierich A, LeMeur M, Mark M, Chambon P: Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression. Cell 66:1105, 1991
84. Chisaka O, Musci T, Capecchi MR: Developmental defects of the ear, cranial nerves, and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6. Nature 355:516, 1992
85. Le Mouellic H, Lallemand Y, Brulet P: Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene. Cell 69 251, 1992
86. Ramirez-Solis R, Zheng H, Whiting J, Krumlauf R, Bradley A: Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell 73:279, 1993
87. Malicki J, Schughart K, McGinnis W: Mouse Hox-2.2 specifies thoracic segment identity in Drosophila embryos and larvae. Cell 63:961, 1990
88. McGinnis N, Kuziora MA, McGinnis W: Human Hox-4.2 and Drosophila Deformed encode similar regulatory specificities in Drosophila embryos and larvae. Cell 63:969, 1990
89. Zhao JJ, Lazzarini RA, Pick L: The mouse Hox-1.3 gene is functionally equivalent to the Drosophila Sex combs reduced gene. Genes Dev 7:343, 1993
90. Regel WA, Singson AW, Margolis JS, Bang AG, Posakony JW, Murre C: Dpbx, a new homeobox gene closely related to the human proto-oncogene Pbx1: Molecular structure and developmental expression. Mech Dev 41:155, 1993
91. Rauskolb C, Peifer M, Weischaus E: extradenticle, a regulator of homeotic gene activity, is a homolog of the homeobox-containing human proto-oncogene pbx1. Cell 74:1101, 1993
92. Burglin TR, Ruvkun G: New motif in PBX genes. Nat Genet 1.319, 1992
93. Johnson A: A combinatorial regulatory circuit in budding yeast. Transcriptional Regul 2:975, 1992
94. Weischaus E, Nüsslein-Volhard C, Jürgens G: Mutations affecting the pattern of the larval cuticle in Drosophila melanogaster. III. Zygotic loci on the X chromosome and the fourth chromosome. Arch Dev Biol 193:267, 1984
95. Peifer M, Weischaus E: Mutations in the Drosophila gene extradenticle affect the way specific homeodomain proteins regulate segmental identity. Genes Dev 4:1209, 1990
96. Chan S-K, Jaffe L, Capovilla M, Botas J, Mann RS: The DNA binding specificity of ultrabithorax is modulated by cooperative interactions with extradenticle, another homeoprotein. Cell 78:603, 1994
97. Rauskolb C, Weischaus E: Coordinate regulation of downstream genes by extradenticle and the homeotic selector proteins. EMBO J 13:3561, 1994
98. van Dijk MA, Murre C: extradenticle raises the DNA binding specificity of homeotic selector gene products. Cell 78:617, 1994
99. Johnson FB, Parker E, Krasnow MA: extradenticle protein is a selective cofactor for the Drosophila homeotics: Role of the homeodomain and YPWM amino acid motif in the interaction. Proc Natl Acad Sci USA 92:739, 1995
100. Hayashi S, Scott MP: What determines the specificity of action of Drosophila homeodomain proteins? Cell 63:883, 1990
101. Chang C-P, Shen W-F, Rozenfeld S, Lawrence HJ, Largman C, Cleary ML: Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev 9:663, 1995
102. Kamps MP, Look AT, Baltimore D: The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev 5.358, 1991
103. Monica K, LeBrun DP, Dedera DA, Brown R, Cleary ML: Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 14:8304, 1994
104. Kamps MP, Baltimore D: E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol 13:351, 1993
105. Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, Cleary ML: Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis and malignant lymphomas in transgenic mice. Cell 74:833, 1993
106. Kamps MP, Wright DD: Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene 9:3159, 1994
107. Raimondi SC, Privitera E, Williams DL, Look AT, Behm F, Rivera GK, Crist WM, Pui C-H: New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. Blood 77:2016, 1991
108. Hunger SP, Devaraj PE, Foroni L, Seeker-Walker LM, Cleary ML: Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL. Blood 83-2970, 1994
109. Devaraj PE, Foroni L, Sekhar M, Butler T, Wright F, Mehta A, Samson D, Prentice HG, Hoffbrand AV, Seeker-Walker LM: E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia. Leukemia 8:1131, 1994
110. Ohyashiki K, Fujieda H, Miyauchi J, Ohyashiki JH, Tauchi T, Saito M, Nakazawa S, Abe K, Yamamoto K, Clark SC, Toyama K. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3. Leukemia 5:322, 1991
111. Hunger SP, Brown R, Cleary ML: DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF. Mol Cell Biol 14:5986, 1994
112. Landschulz WH, Johnson PF, McKnight SL: The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 240:1559, 1988
113. O'Shea EK, Klemm JD, Kim PS, Alber T: X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254-539, 1991
114. Ellenberger TE, Brandl CJ, Struhl K, Harrison SC: The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted z helices: Crystal structure of the protein-DNA complex. Cell 71:1223, 1992
115. Mueller CR, Maire P, Schibler U: DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally. Cell 61:279, 1990
116. Drolet DW, Scully KM, Simmons DM, Wegner M, Chu K, Swanson LW, Rosenfeld MG: TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes Dev 5:1739, 1991
117. Iyer SV, Davis DL, Sea SN, Burch JB: Chicken vitellogenin gene-binding protein, a leucine zipper transcription factor that binds to an important control element in the chicken vitellogenin II promoter, is related to rat DBP. Mol Cell Biol 11.4863, 1991
118. Wuarin J, Schibler U: Expression of the liver-enriched transcriptional activator DBP follows a stringent circadian rhythm. Cell 63:1257, 1990
119. Yano M, Falver E, Gonzalez FJ: Role of the liver-enriched transcription factor DBP in expression of the cytochrome P450 CYP2C6 gene. Mol Cell Biol 12:2847, 1992
120. Lavery DJ, Schibler U: Circadian transcription of the cholesterol 7α hydroxylase gene may involve the liver-enriched bZIP protein DBP. Genes Dev 7:1871, 1993
121. Lee Y-H, Alberta JA, Gonzalez FJ, Waxman DJ: Multiple, functional DBP sites on the promoter of the cholesterol 7α-hydroxylase P450 gene, CYP7. J Biol Chem 269:14681, 1994
122. Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, Look AT: DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Mol Cell Biol 14:3403, 1994
123. Vinson CR, Hai T, Boyd SM: Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: Prediction and rational design. Genes Dev 7:1047, 1993
124. Yoshihara T, Inaba T, Shapiro LH, Kato J-Y, Look AT: E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol Cell Biol 15:3247, 1995
125. Cowell IG, Skinner A, Hurst HC: Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol Cell Biol 12:3070, 1992
126. Inaba T, Yoshihara T, Zhang W, Nimer S, Look AT: The mechanism of transformation by E2A-HLF may involve genes normally regulated by NF-IL3/E4BP4. Blood 84:439a, 1994 (abstr, suppl 1)
127. Fitzgerald TJ, Neale GAM, Raimonndi SC, Goorha RM: c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-β chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). J Exp Med 176:1303, 1992
128. Begley CG, Aplan PD, Denning SM, Haynes CBF, Waldmann TA, Kirsch IR: The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 86:10128, 1989
129. Finger LR, Kagan J, Christopher G, Kurtzberg J, Herschfield MS, Nowell PC, Croce CM: Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 86:5039, 1989
130. Chen Q, Cheng JT, Tsai LH, Schneider N, Buchanan G, Carroll A, Crist W, Ozanne B, Siciliano MJ, Baer R: The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 9:415, 1990
131. Bernard O, Guglielmi P, Jonveaux P, Cherif D, Gisselbrecht S, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D: Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosom Cancer 1:194, 1990
132. Aplan PD, Raimondi SC, Kirsch IR: Disruption of the SCL gene by a t(1;13) translocation in a patient with T cell acute lymphoblastic leukemia. J Exp Med 176:1303, 1992
133. Brown L, Cheng J-T, Chen Q, Siciliano MJ, Crist WM, Buchanan G, Baer R: Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J 9:3343, 1990
134. Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D: Two site-specific deletions and t(1:14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 6:1477, 1991
135. Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR: Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79:1327, 1992
136. Mellentin JD, Smith SD, Cleary ML: lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 58:77, 1989
137. Xia Y, Brown L, Yang CY, Tsan JT, Siciliano MJ, Espinosa R III, Le Beau MM, Baer RJ: TAL2, a helix-loop-helix gene activated by the t(7;9)(q34;q32) translocation in human T cell leukemia. Proc Natl Acad Sci USA 88:11416, 1991
138. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/ SCL. Nature 373:432, 1995
139. Hsu H-L, Huang L, Tsan JT, Funk W, Wright WE, Hu J-S, Kingston RE, Baer R: Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol 14:1256, 1994
140. Xia Y, Hwang L-H, Cobb MH, Baer RJ: Products of the TAL2, oncogene in leukemia T cells: bHLH phosphoproteins with DNA-binding activity. Oncogene 9:1437, 1994
141. Baer R: TAL1, TAL2 and LYL1: A family of basic helix-loop-helix proteins implicated in T cell acute leukemia. Semin Cancer Biol 4:341, 1993